References
- Zhong JH, Ma L, Li LQ, Ru HM, Zhao YN. Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems. Scand J Gastroenterol 2011;46:645–51.
- Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol 2011;46:663–72.
- Strid H, Simrén M, Störsrud S, Stotzer PO, Sadik R. Effect of heavy exercise on gastrointestinal transit in endurance athletes. Scand J Gastroenterol 2011;46:673–7.
- Morimoto K, Hosomi S, Yamagami H, Watanabe K, Kamata N, Sogowa M, Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease. Scand J Gastroenterol 2011;46:701–9.
- Fernández-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM. Percutaneous liver biopsy: patients' point of view. Scand J Gastroenterol 2011;46:727–31.
- Efe C, Purnak T, Ozaslan E, Ozbalkan Z, Karaaslan Y, Altiparmak E, Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol 2011;46:732–7.
- Schult A, Eriksson H, Wallerstedt S, Kaczynski J. Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. Scand J Gastroenterol 2011;46:738–44.
- Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 2011;46:750–9.
- Andersen ES, Weiland O, Leutscher P, Krarup H, Westin J, Moessner B, Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scand J Gastroenterol 2011;46:760–6.